Antityrosine kinase antibody fms 3 (FLT3), pharmaceuticals containing Anti-FLT3 antibodies, the isolated nucleic acid molecule, and the method for manufacturing this Anti-FLT3 antibody

VN10059277BActive Publication Date: 2026-07-15LES LAB SERVIER SA

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: VN1202207335
Authority / Receiving Office: VN · VN
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2021-04-14
Publication Date: 2026-07-15
Estimated Expiration: 2041-04-14

Application Information

Patent Timeline

14 Apr 2021

Application

VN1202207335

15 Jul 2026

Publication

VN10059277B

Inventors: LINDSTED, Trine; MELANDER, Eva, Maria, Carlsen

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to anti-FLT3 antibodies. These antibodies are useful in enhancing immunity in patients requiring treatment and in the treatment of cancer. The invention relates to a pharmaceutical containing this anti-FLT3 antibody, an isolated nucleic acid molecule containing a ligand sequence, a double-specific binding molecule comprising the antigenic binding domain of one or two distinct anti-FLT3 antibodies, and a method for producing anti-FLT3 antibodies.

Need to check novelty before this filing date? Find Prior Art